Lidocaïne Hcl Cf (Lidocaine Hydrochloride)

Lidocaine blocks voltage‑gated sodium channels on nerve and cardiac cells, preventing sodium influx during depolarisation. This stops the propagation of electrical impulses, producing loss of sensation in the targeted area and, in the heart, stabilising abnormal rhythm.

The specific dose of Lidocaïne Hcl Cf is determined by the prescribing clinician based on the indication, patient weight, age, and clinical condition. Healthcare professionals adjust the amount to achieve the desired anesthetic or anti‑arrhythmic effect while monitoring safety.

Safety data for lidocaine hydrochloride in pregnancy and lactation are limited. It is classified as pregnancy category unknown, so clinicians must weigh potential benefits against possible risks and consider alternative therapies when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and required import documentation.

Lidocaine has a rapid onset and moderate duration, making it suitable for short procedures and emergency cardiac use. Compared with bupivacaine, which lasts longer but has a slower onset, lidocaine offers quicker pain relief but may require repeat dosing for prolonged surgeries.

Lidocaïne Hcl Cf should be stored at controlled room temperature (15‑30 °C) in its original sealed container, protected from light and moisture. Do not freeze the solution, and keep it out of direct sunlight to maintain stability.

The product is supplied as a sterile solution for intravenous injection. Administration is performed by a qualified healthcare professional, who injects the prescribed volume directly into a vein, often using an infusion pump or syringe, depending on the clinical scenario.

Serious adverse events include severe hypotension, life‑threatening cardiac arrhythmias, anaphylactic reactions, methemoglobinemia, and central nervous system toxicity such as seizures. Prompt recognition and supportive measures are essential if these occur.

Patients with known hypersensitivity to lidocaine or other amide‑type local anesthetics should avoid this product. It is also contraindicated in individuals with severe heart block, uncontrolled heart failure, or those taking certain antiarrhythmic drugs that may precipitate toxicity.